Prof. Shilpa Chokshi is a translational scientist in the field of hepatology, with research interests that span viral hepatitis, alcoholic liver disease, the immune mechanisms driving cirrhosis, and the development of immunotherapeutic treatments for hepatocellular carcinoma. She currently holds the position of Professor of Experimental Hepatology at King’s College London and serves as the Acting Director and Chief Scientific Officer for the Roger Williams Institute of Hepatology. Here, she leads an active research program, providing both scientific and academic leadership. Prof. Shilpa Chokshi’s research strategy is dedicated to “supporting research into liver diseases that yield tangible clinical benefits for patients” and she leads a research portfolio that encompasses a wide spectrum of clinical manifestations of liver disease, all categorized under the umbrella of “Mechanisms of Hepatic Injury and Repair”. The collective focus of these studies is fundamental discovery-based studies to identify novel drug targets and biomarkers, aimed at tackling the intricate challenges associated with treating liver disorders.